Skip to main content

Table 2 Independent cohort of patients used for validation (Centre Léon Bérard, Lyon, France): characteristics of the 33 patients with initially ER-positive primary breast cancer

From: A candidate molecular signature associated with tamoxifen failure in primary breast cancer

Characteristic

Control group (n = 19)

TF group (n = 14)

P a

Age (years)

   

   <70

16

8

NS (0.18)

   ≥ 70

3

6

 

Histological grade

   

   I + II

12

8

NS (1)

   III

7

6

 

Lymph node status

   

   Node negative

0

0

NS (1)

   Node positive

19

14

 

Macroscopic tumor size

   

   <30 mm

10

9

NS (0.75)

   ≥ 30 mm

9

5

 
  1. aP value (χ2 test) was considered significant when P < 0.05. ER, estrogen receptor; NS, not significant; TF, tamoxifen failure.